Devonian Health Group Inc. (TSXV:GSD)
Canada · Delayed Price · Currency is CAD 8.49
-0.51 (-5.67%)
Jul 21, 2026, 9:30 AM EST
Devonian Health Group Market Cap
Devonian Health Group has a market cap or net worth of CAD 25.03 million as of July 21, 2026. Its market cap has increased by 12.57% in one year.
Market Cap
25.03M
Enterprise Value
24.45M
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.49
ChartMarket Cap Chart
Since May 19, 2017, Devonian Health Group's market cap has decreased from 1.44B to 25.03M, a decrease of -98.26%. That is a compound annual growth rate of -35.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 25.03M | -20.62% |
| Dec 24, 2025 | 31.53M | 32.95% |
| Dec 30, 2024 | 23.72M | 11.47% |
| Dec 21, 2023 | 21.28M | -52.33% |
| Dec 21, 2022 | 44.63M | -94.11% |
| Dec 31, 2021 | 758.36M | 359.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medicenna Therapeutics | 32.31M |
| Defence Therapeutics | 31.83M |
| Thiogenesis Therapeutics | 29.55M |
| Quantum BioPharma | 28.79M |
| Lobe Sciences | 28.41M |
| Sharp Therapeutics | 27.37M |
| Alzai Health | 25.02M |
| Pharmala Biotech Holdings | 16.33M |